These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
860 related articles for article (PubMed ID: 27091932)
1. CD47-SIRPα Interactions Regulate Macrophage Uptake of Plasmodium falciparum-Infected Erythrocytes and Clearance of Malaria In Vivo. Ayi K; Lu Z; Serghides L; Ho JM; Finney C; Wang JCY; Liles WC; Kain KC Infect Immun; 2016 Jul; 84(7):2002-2011. PubMed ID: 27091932 [TBL] [Abstract][Full Text] [Related]
2. Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPα (signal regulatory protein-α) on phagocytes. Gitik M; Liraz-Zaltsman S; Oldenborg PA; Reichert F; Rotshenker S J Neuroinflammation; 2011 Mar; 8():24. PubMed ID: 21401967 [TBL] [Abstract][Full Text] [Related]
3. Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis. Koh E; Lee EJ; Nam GH; Hong Y; Cho E; Yang Y; Kim IS Biomaterials; 2017 Mar; 121():121-129. PubMed ID: 28086180 [TBL] [Abstract][Full Text] [Related]
4. Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts. Theocharides AP; Jin L; Cheng PY; Prasolava TK; Malko AV; Ho JM; Poeppl AG; van Rooijen N; Minden MD; Danska JS; Dick JE; Wang JC J Exp Med; 2012 Sep; 209(10):1883-99. PubMed ID: 22945919 [TBL] [Abstract][Full Text] [Related]
6. Attenuation of phagocytosis of xenogeneic cells by manipulating CD47. Wang H; VerHalen J; Madariaga ML; Xiang S; Wang S; Lan P; Oldenborg PA; Sykes M; Yang YG Blood; 2007 Jan; 109(2):836-42. PubMed ID: 17008545 [TBL] [Abstract][Full Text] [Related]
7. Cd47-Sirpα interaction and IL-10 constrain inflammation-induced macrophage phagocytosis of healthy self-cells. Bian Z; Shi L; Guo YL; Lv Z; Tang C; Niu S; Tremblay A; Venkataramani M; Culpepper C; Li L; Zhou Z; Mansour A; Zhang Y; Gewirtz A; Kidder K; Zen K; Liu Y Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5434-43. PubMed ID: 27578867 [TBL] [Abstract][Full Text] [Related]
8. Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma. Zhang X; Chen W; Fan J; Wang S; Xian Z; Luan J; Li Y; Wang Y; Nan Y; Luo M; Li S; Tian W; Ju D Carcinogenesis; 2018 May; 39(5):689-699. PubMed ID: 29538621 [TBL] [Abstract][Full Text] [Related]
9. Cancer immunotherapy targeting the CD47/SIRPα axis. Weiskopf K Eur J Cancer; 2017 May; 76():100-109. PubMed ID: 28286286 [TBL] [Abstract][Full Text] [Related]
10. Human CD47 expression permits survival of porcine cells in immunodeficient mice that express SIRPα capable of binding to human CD47. Wang C; Wang H; Ide K; Wang Y; Van Rooijen N; Ohdan H; Yang YG Cell Transplant; 2011; 20(11-12):1915-20. PubMed ID: 21535911 [TBL] [Abstract][Full Text] [Related]
11. "Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis. Ho CC; Guo N; Sockolosky JT; Ring AM; Weiskopf K; Özkan E; Mori Y; Weissman IL; Garcia KC J Biol Chem; 2015 May; 290(20):12650-63. PubMed ID: 25837251 [TBL] [Abstract][Full Text] [Related]
12. Notch Signaling Modulates Macrophage Polarization and Phagocytosis Through Direct Suppression of Signal Regulatory Protein α Expression. Lin Y; Zhao JL; Zheng QJ; Jiang X; Tian J; Liang SQ; Guo HW; Qin HY; Liang YM; Han H Front Immunol; 2018; 9():1744. PubMed ID: 30105024 [TBL] [Abstract][Full Text] [Related]
13. Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system. Okazawa H; Motegi S; Ohyama N; Ohnishi H; Tomizawa T; Kaneko Y; Oldenborg PA; Ishikawa O; Matozaki T J Immunol; 2005 Feb; 174(4):2004-11. PubMed ID: 15699129 [TBL] [Abstract][Full Text] [Related]
14. CD47 blockade reduces the pathologic features of experimental cerebral malaria and promotes survival of hosts with Torrez Dulgeroff LB; Oakley MS; Tal MC; Yiu YY; He JQ; Shoham M; Majam V; Okoth WA; Malla P; Kumar S; Weissman IL Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836556 [TBL] [Abstract][Full Text] [Related]
15. Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity. Kuo TC; Chen A; Harrabi O; Sockolosky JT; Zhang A; Sangalang E; Doyle LV; Kauder SE; Fontaine D; Bollini S; Han B; Fu YX; Sim J; Pons J; Wan HI J Hematol Oncol; 2020 Nov; 13(1):160. PubMed ID: 33256806 [TBL] [Abstract][Full Text] [Related]
16. The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer. Matlung HL; Szilagyi K; Barclay NA; van den Berg TK Immunol Rev; 2017 Mar; 276(1):145-164. PubMed ID: 28258703 [TBL] [Abstract][Full Text] [Related]
17. CD40 Enhances Type I Interferon Responses Downstream of CD47 Blockade, Bridging Innate and Adaptive Immunity. de Silva S; Fromm G; Shuptrine CW; Johannes K; Patel A; Yoo KJ; Huang K; Schreiber TH Cancer Immunol Res; 2020 Feb; 8(2):230-245. PubMed ID: 31852716 [TBL] [Abstract][Full Text] [Related]